Sandoz Partner Gan & Lee Wraps Phase III Insulin Glargine Trial

Follows Earlier Positive Phase I Clinal Data For Biosimilar Rival To Lantus

Diabetes; Chalkboard on a wooden background
Gan & Lee And Sandoz Have Been Partners Since Late 2018 • Source: Alamy

More from Biosimilars

More from Products